Kenneth J. Tarpey
Analyst · Youssef Squali with Cantor Fitzgerald
Thank you, Magid. Reported revenue for the fourth quarter was $68.4 million, up 9% year-over-year. On a non-GAAP pro forma basis, excluding the financial performance of our non-health copy testing and Configuration Manager products, which Magid mentioned earlier, which we expect to divest or eliminate, revenue grew 12%. Subscription revenue in the fourth quarter was a quarterly record of $58.4 million, up 12% year-over-year. Subscription revenue represents 85% of total revenue, a consistent trend. Project revenue was $10 million or 15% of revenue, also consistent with prior trends. GAAP revenue from existing customers was up 8% year-over-year in the fourth quarter to $60.4 million, and represented 88% of total revenues. On the pro forma basis, existing customer revenue in the fourth quarter of 2012 was up 10% year-over-year. Our renewal rate with existing customers remained above 90% on a constant dollar basis, and we added 45 net new customers in the fourth quarter, with our customer count now totaling 2,159. Our focus on international expansion continues to drive an increase in International revenues. In the fourth quarter, revenue from outside the United States was $20.5 million or 30% of revenue, and was up 20% year-over-year. Our top 10 customers represent 21% of revenue in the fourth quarter, reflecting the continued diversification in our overall customer base. Now let me turn to expenses and margins. Our gross margin was 65.4%, down slightly as we strategically invest to support our expanding multi-platform and cross media sales initiatives. As we expand our cross sell and upsell efforts with these products, we expect the resulting operating leverage will drive improvement in our gross margin throughout 2013. In preparing for 2013, we have streamlined processes and identified service offerings for disposition or deemphasis. We also looked to other cost areas for expense optimization opportunities. These efforts identified annual expense savings of approximately $9 million. We're implementing these changes over the course of 2013 while also making modest targeted investments, primarily in sales and marketing efforts for these strategic priorities, which Magid just discussed. GAAP pretax loss was $1.9 million in the fourth quarter, as compared to a GAAP pretax loss of $4.4 million in the fourth quarter of 2011. Our effective GAAP income tax rate in the fourth quarter was a 14% tax benefit rate due to the current booked pretax loss position. GAAP net loss was $1.6 million or $0.05 per basic share and diluted share in the fourth quarter of 2012 based on a basic and diluted share count of 33.7 million shares. Non-GAAP net income for the fourth quarter of 2012 was $7.9 million or $0.22 per diluted share, excluding litigation costs, stock-based compensation, amortization of intangibles, acquisitions-related expenses, restructuring and other nonrecurring items. This amount compares to a non-GAAP net income of $11.8 million or $0.35 per diluted share in the fourth quarter of 2011. We believe that adjusted EBITDA is a useful measure for investors to use to evaluate our operating performance. Adjusted EBITDA takes non-GAAP net income and adjusts it to exclude the cash tax provision, depreciation, intangible amortization cost, stock-based compensation expense, acquisition-related expenses, litigation costs, net interest income, restructuring and other nonrecurring items. On this basis, adjusted EBITDA was $12.2 million in the fourth quarter and represented an adjusted EBITDA margin of 18%. This compares to an adjusted EBITDA of $15.4 million in the fourth quarter of 2011. This decline primarily reflected the reduced contribution from the non-health copy testing and configuration manager products and the lag in revenue conversion for vCE, DAx and other mobile Operator Analytix bookings. Now looking at our results for the full year, reported revenue was $255.2 million, up 10% from 2011. Excluding the financial impact of our discontinued and deemphasized offerings, 2012 revenue grew 13% on a non-GAAP pro forma basis. GAAP pretax loss was $9.4 million and GAAP net loss was $11.8 million or $0.35 per basic and diluted share. Non-GAAP net income was $28.1 million or $0.79 per diluted share, and adjusted EBITDA was $44.4 million. While the adjusted EBITDA margin of 17% for 2012 was impacted by expenses associated with our expanded analytics offerings, we believe improving margin trends that we reported in the second half of 2012 will continue during 2013. Our full-year GAAP tax rate was 25%, and our cash tax rate was 16%. We continue to hold significant net operating loss carryforwards in the United States, certain U.S. states, as well as foreign jurisdictions predominantly the Netherlands and to a lesser extent, the U.K. Turning to our balance sheet. We ended the year with cash and cash equivalents of $61.8 million, an increase of $2.6 million from September 30 and an increase of $23.7 million from a year ago. Our receivables of $68.3 million increased from $64.4 million a year ago due to the growth of our business. Total deferred revenue was $82.5 million, up 17% from a year ago, with current deferred revenue of $80.8 million and an increase of 18% from the end of 2011, which reflects our strong bookings growth. The majority of our subscription deferred revenue was composed of contracts rewritable revenue recognition, which provides us with high near-term visibility. It was a smaller component of deferred revenue for vCE, for example, whose revenue recognition can be dependent on the timing of customer campaigns. Additionally, it should be noted that current deferred revenue does not represent the full anticipated billings value of current customers over the next 12 months as some customers have moved from annual billing to multiple billing cycles per year. Cash flow from operations for the fourth quarter of 2012 was $11.7 million. Our capital expenditures were $2.6 million in the quarter. This resulted in a free cash flow for the fourth quarter of $9.1 million. Looking at the year, cash flow from operations was $44.9 million, a 68% increase from cash flow from operations of $26.8 million in 2011. Our capital expenditures for the full year were $7.6 million, which resulted in a 2012 free cash flow of $37.3 million. In summary, while 2012 was a tough year, we ended it on a strong note and believe the actions we have taken position us well for 2013 and beyond. We continue to make progress in transforming comScore from a focused data company to a software and analytics company. Our core businesses are strong, and our new products are gaining good traction. We are focused on execution and generating operating leverage. Now I would turn your attention to Slides 13 and 14 of our slide deck, which relate to 2013 guidance. As we turn to those slides and that guidance, as Magid indicated, we're committed to delivering top line growth with margin improvements. We believe our strong bookings growth in 2012 positions us well to deliver faster revenue growth in 2013. At the same time, healthy pipeline trends across our product portfolio suggest our recent booking trend should continue, though we expect some back end waiting, 2 bookings during the year, due to, primarily, the renewal cycles of our customers. We are committed to improving profitability, and I mentioned a number of steps we believe can reduce our annualized cost structure by approximately $9 million in 2013. At the same time, we will -- we expect restructuring actions we are taking in the first quarter to reinforce our focus on improving efficiencies enterprise-wide, as well as permit necessary investment to some extent to support the offerings of our newer products. So with that backdrop, we anticipate full year revenue for 2013 to be between $273.4 million and $283.2 million, representing a growth of 7% to 11% as compared to 2012 GAAP revenues. However, on a non-GAAP pro forma basis, excluding the financial performance of our non-health copy testing and Configuration Manager products, 2013 revenue growth range is 11% to 15%. From a profitability perspective, we anticipate GAAP income loss before income taxes to be in the range of an $8.1 million loss to a $1.0 million income. We anticipate adjusted EBITDA to be between $46 million and $54 million in 2013, representing an adjusted EBITDA margin range of approximately 17% to 19%. Currently for 2013, we project an annual GAAP tax rate approximately 50% and an annual cash tax rate of 15%. For 2013, we expect approximately $8.1 million in amortization of intangibles and patents and $26.4 million in stock-based compensation. For the full year of 2013, we anticipate average fully diluted share count of 37.8 million. Now for focus on the first quarter of 2013, we anticipate revenues in the range of $65.8 million to $67.2 million, which represents an expected increase of 6% to 8% over the first quarter of 2012 on an as reported basis. However, on a non-GAAP pro forma basis, excluding the financial performance of our non-health copy testing and Configuration Manager products, Q1 2013 revenue growth is 9% to 12%. We anticipate first quarter GAAP loss before income taxes in the range of $4.3 million loss to $3.1 million loss. We anticipate adjusted EBITDA for the first quarter of 2013 to be in the range of $10 million to $11.2 million, which represents an adjusted EBITDA margin of 16% at the midpoint of our revenue and adjusted EBITDA guidance. Our estimated fully diluted share count for the first quarter is 37.3 million shares. A reconciliation of GAAP net income, net loss before income taxes to adjusted EBITDA guidance for the first quarter and full year of 2013 is included in the tables to our earnings press release as well as the slides I mentioned before. And Slide 19, for your use, we are providing comparative 2012 information for the pro forma -- or products, which we are divesting or eliminating so you get a sense of the revenue and EBITDA contribution of those products during the quarters of 2012. Now with that, operator, we can open the lines to take questions.